p.24.0013886

proceeding

ACT_13886/2024 UPC_CFI_124/2024

ACT_13886/2024 - Application for provisional measures (RoP206)

2024

Hamburg Local Division - First Instance

Date of Filing: 19/03/24

Registry Numbers: ACT_13886/2024 UPC_CFI_124/2024

Case Title:

Patents

EP3167888

Patents

EP3167888

TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENTS BY AN INHIBITOR OF COMPLEMENT

Parties

Applicant 1. Alexion Pharmaceuticals, Inc.

Defendant 2. Amgen Technology (Ireland) Unlimited Company

Defendant 3. Amgen N.V.

Defendant 4. Amgen GmbH

Defendant 5. Amgen GmbH

Defendant 6. Amgen AB

Defendant 7. Amgen S.A.S.

Defendant 8. Amgen s.r.l.

Defendant 9. Amgen Biofarmacêutica Lda.

Defendant 10. Amgen Zdravila D.O.O.